Month: January 2022

Innovative series to highlight Jushi’s leading operational footprint, national expansion plans, and M&A strategy BOCA RATON, Fla., Jan. 31, 2022 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, today announced that it launched a new investor-focused video series. The series will highlight the Company’s current market position, including its industry-leading operational footprint, national expansion plans, and targeted M&A strategy. Viewers will also be introduced to Jushi’s leadership team, beginning with Jim Cacioppo, Chief Executive Officer, Chairman and Founder of Jushi. “We are incredibly excited to launch an investor video update series which will provide viewers with both a deep understanding of where we are today...

BOTHELL, Wash., Jan. 31, 2022 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced the appointment of Grant Pickering to its Board of Directors. Mr. Pickering is Chief Executive Officer, co-founder and member of the Board of Directors at Vaxcyte, Inc. (NASDAQ: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. “Grant is an accomplished life sciences leader with considerable experience across all stages of development and commercialization of new medicines,” said Mark Litton, Ph.D., President and Chief Executive Officer at Athira. “His deep experience in the biopharma industry provides a...

Bousquet Drilling ResultsBousquet Drilling ResultsVisible GoldVisible gold on BO-21-08 at 184MMONTREAL, Jan. 31, 2022 (GLOBE NEWSWIRE) — Bullion Gold Resources Corp. (TSX-V: BGD) (“Bullion Gold” or the “Corporation”) announces that it has completed a first drilling program of nine holes totaling 2,381 meters on the Bousquet project, located over more than 7 km along the Cadillac-Larder Lake fault, in the Rouyn-Noranda region, in Quebec. These holes drilled to verify the historical data of the Paquin-Est, Paquin Ouest and Decoeur zones confirm the presence of gold, most of which have intersected several significant gold values in zones of deformation and silicification strongly mineralized. Located in the Paquin East zone, hole BO-21-08 intersected a 9-meter gold section grading 16.96 g/t Au including...

On 28 September 2021, MT Højgaard Holding A/S announced that a share buy-back programme of up to 40,000 treasury shares at an aggregated price of up to DKK 11,000,000 was launched with the purpose to meet obligations arising from the company’s share-based incentive programme. The share buy-back programme is executed pursuant to the so-called ”Safe Harbour” provisions in Regulation (EU) No. 596/2014 of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016. The programme will end no later than on 18 March 2022. The following transactions have been executed from 24-28 January 2022:   Number ofshares Average purchaseprice (DKK) Transactionvalue (DKK)Accumulated, last announcement 33,019 205.25 6,777,07624 January 202225 January 202226 January 202227 January 202228 January 2022 310350350300300 199.57197.86199.87199.68198.00 61,86769,25169,95559,90459,400Accumulated...

R1 received 100% ranking and was named one of the Best Places to Work for LGBTQ+ Equality MURRAY, Utah, Jan. 31, 2022 (GLOBE NEWSWIRE) — R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, proudly announced that it received a 100% ranking on the Human Rights Campaign Foundation’s (HRC) 2022 Corporate Equality Index (CEI), the nation’s foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality. R1 joins the ranks of over 840 U.S. businesses that also earned top marks this year. “We’re proud to receive the designation as one of the Best Places to Work for LGBTQ+ Equality,” said Joe Flanagan, chief executive officer of R1. “While we know there’s more work...

RESEARCH TRIANGLE PARK, N.C., Jan. 31, 2022 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARK™ (a unique formulation of sodium thiosulfate) for the prevention of platinum-induced ototoxicity in pediatric patients, today announced that Shubh Goel, the Company’s chief commercial officer, has tendered her resignation and will depart Fennec in late February. “On behalf of the Board of Directors and leadership team, we thank Shubh for her many contributions to the Company. We continue to prepare for a commercial launch upon approval,” said Rosty Raykov, chief executive officer of Fennec Pharmaceuticals, Inc. “Fennec remains committed to making PEDMARK™ available to children and young adults receiving cisplatin chemotherapy, who currently have...